The Biomedical Research Foundation Academy of Athens (BRFAA), nominated for the “Innovation Radar Prize 2019

September 2019

The Biomedical Research Foundation Academy of Athens (BRFAA), partner in CURE, was selected in July 2019 as one of the 36 finalists for the prestigious European Commission’s “Innovation Radar Prize 2019” under the “Innovative Science” category, linked to their research in CURE.

The Biomedical Research Foundation Academy of Athens (BRFAA), partner in CURE, was selected in July 2019 as one of the 36 finalists for the prestigious European Commission’s “Innovation Radar Prize 2019” under the “Innovative Science” category, linked to their research in CURE.

The Innovation Radar is an initiative from the European Commission to identify high quality innovations from EU-funded research projects grouped under 4 categories: Tech for Society, Innovative Science, Industrial & Enabling Tech and Women-led innovations. A public poll was open to vote for the best 3 EU-funded innovators of each category.

The 12 finalists (3 in each category), in terms of votes cast, were selected to the finals. A jury of experts reviewed the candidates and announce the winner at the Research and Innovations Days in Brussels (24, 25 and 26 September 2019). We are proud that BRFAA was initially nominated for the prize and reached a good number of votes.

Congratulations to the 3 finalists. These were Oslo University Hospital, Space Structures and Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften.

© 2017 Cure. Eubiosis Reinstatement Therapy

  • Twitter Social Icon

 

 

 

 

 

This project has received funding from the European Union’s Horizon 2020 research

and innovation programme under grant agreement No 767015.

The content of this website reflects only the views of its authors.

The European Commission is not responsible for any use that may be made of the information it contains